BIO21- CHITOSAN specialist manufacturer
BIO21- CHITOSAN specialist manufacturer
Slider

BIO21 company limited in Thailand

is One of Specialists Manufacturing CHITOSAN variences as a raw material for any applications, dietary / medical device "CHITOSAN spec l112",  a semi-finished of dietary/medical device "CHITOSAN L112 BIOPOLYMER", which all of CHITOSAN products from the knowledge of chemistry technology and biotechnology including research & development and the experienced industrial production scale with the quality control system QMS standard.

We are CHITOSAN manufactuer and exporter since 2005 , our well know CHITOSAN products are CHITOSAN L112 BIOPOLYMER and CHITOSAN spec L112, we have been exporting to USA, EU, JAPAN and ASIAN.

We have experienced in long time of production  raw materials "CHITIN" of  CHITOSAN  for commercial and our in-house production.

And we have one CHITOSAN dietaty finished product for consumer L112 ABSORBITAL

We have two processing factories;

• in Samuthsakorn Thailand since 2005

• in Banyuwangi East Jawa Indonesia since 2015

April 2001

From the Vision, Commitment and Belief in the concept including a basic knowledge of chemistry and biotechnology jointly established the AQUA PREMIER (Bannawach Bio-Line) Purposes for manufacturing  CHITOSAN and CHITOSAN applications.

2003

Manufacturing CHITIN in industrial scale, we are one of main suppliers for  the company from EU which production Glucosamine product

 

2004

The 1st production plant construction propose for expanding capacity  in the name of Bannawach Bio-Line Co.,Ltd.

 

2005-2008 

A member in R&D team in part of CHITOSAN preparation for  Enhance CHITOSAN derivative for dietary supplement , L112 BIOPOLYMER and CHITOSAN spec L112  in research and development of  OPTIMIZING CHITOSAN CHARACTERISTICS FOR EFFECTIVE USE IN HUMAN WEIGHT-LOSS REGIMENS  PHASE I & II STUDY: CHITOSANS OF INTEREST, and PHASE III STUDY: CHITOSANS OF INTEREST IN RATS

Investment in  equipment, machinery, lab-room, lab-equipment and clean-room class 100k environment for manufacturing L112 BIOPOLYMER and CHITOSAN in medical device grade and food grade  included implementing the QMS (Quality Management System)

Manufacturing CHITOSAN purpose for exporting and in-house use for L112 BIOPOLYMER

Manufacturing L112 BIOPOLYMER export to USA and re-export to EU  finished-product wide-popular in EU countries

CHITIN product manufacturing for customer from Japan, we have expanded CHITIN production capacity to Indonesia factory  

 

November 2008 

Mr. Kasem and Mr. Paisan have chosen to walkaway out from the Bannawach Bio-line factory with shareholder reasons. The BIO21 established along with the first strategic plan "manufacturing special CHITOSAN and CHITOSAN application products"

Continue research and development in CHITOSAN and L112 BIOPOLYMER

launch finished-product  L112 ABSORBITAL, Natural fibre fat binding tablets and capsule type for consumer and OEM

Continue in CHITOSAN applications research and development, Manufacturing and selling CHITOSAN and CHITOSAN application such as CHITOSAN for agiculture  CHITOSAN Plant-Elicitor

 

 2010

  • Start a new one CHITOSAN  factory at Samutsakorn province  for marketing and selling proposes in EU , USA   Asia markets 
  • Launch New L112 ABSORBITAL and Advance-L112 ABSORBITAL products

2012

  • Start the food grade / dietary supplement CHITOSAN and medical device CHITOSAN for JAPAN and ASIAN 

2013

  • Launch a new CHITOSAN application in agricultural product "FCR additive"  for broiler farm by R&D  including  test run at the prototype farm  (EVAP farm system)

 2014

  • Restart the  dietary supplement / medical device CHITOSAN business with a customer from EU country

2015

  • The second CHITOSAN factory  in Banyuwangi Indonesia ready for production industrial grade and food grade CHITOSAN.

2018

  • Signed the Agreement on quality assurance for CHITOSAN supplies for EU customer 
  • Started a production of fish scale OSSEIN at Indonesia factory, purposes for commercial and in-house used in COLLAGEN production in future.